Braveheart Investment Group plc Further update re Paraytec AD Scanner project
04 Agosto 2021 - 10:40AM
RNS Non-Regulatory
TIDMBRH
Braveheart Investment Group plc
04 August 2021
Reach - a non-regulatory announcement
4 August 2021
Braveheart Investment Group plc
("Braveheart" or the "Group")
Further update re Paraytec AD Scanner project
Further to the announcement on 14 June 2021, Braveheart
Investment Group plc (AIM: BRH), regarding Paraytec's work with
partners in the field of Alzheimer's disease (AD) detection and
also the Covid-19 detection project.
Prototype instruments were shipped to project partners in early
July 2021 and sample testing has commenced. The initial results
from Vrije University Medical Centre Amsterdam (VUMC) using AD
patient samples were inconclusive. The cause and implications of
these initial results are not yet known. Further testing is needed
and although the funded project will end at the end of this month,
Paraytec's partners have indicated that they will continue the
testing thereafter. A further update is expected by the end of
September 2021.
Paraytec's work to develop an instrument for the detection of
COVID-19 is progressing as planned and a corporate finance
specialist has been engaged to market the technology to potential
partners or acquirers.
We anticipate releasing the next update for both the COVID-19
and AD scanner projects will be around the end of September
2021.
For further information:
Braveheart Investment Group plc Tel: 01738
587555
Trevor Brown CEO
Allenby Capital Limited (Nominated Tel: 020
Adviser and Joint Broker) 3328 5656
David Worlidge / James Reeve / George
Payne
Peterhouse Capital Limited (Joint Tel: 020
Broker) 7469 0936
Heena Karani / Lucy Williams
About Reach announcements
This is a Reach announcement. Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM
quoted) companies to distribute media only / non-regulatory news
releases into the public domain. Information required to be
notified under the AIM Rules for Companies, Market Abuse Regulation
or other regulation would be disseminated as an RNS regulatory
announcement and not on Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAXZLFBFVLXBBD
(END) Dow Jones Newswires
August 04, 2021 09:40 ET (13:40 GMT)
Braveheart Investment (LSE:BRH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Braveheart Investment (LSE:BRH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024